According to Bloomberg, a Johnson & Johnson (JNJ) unit never warned users of the Levaquin antibiotic that it posed a greater risk of tendon damage than rival medications, a lawyer for two men suing the company said today. To contact the reporter on this story: Jef Feeley in Atlantic City, New Jersey, at jfeeley@bloomberg.net
